Anebulo Pharmaceuticals Q1 EPS $(0.10) Beats $(0.12) Estimate
Anebulo Pharmaceuticals Q1 EPS $(0.10) Beats $(0.12) Estimate
Anebulo Pharmicals 第一季度每股收益(0.10 美元)高于美元(0.12)的预期
Anebulo Pharmaceuticals (NASDAQ:ANEB) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.12) by 16.67 percent. This is a 9.09 percent increase over losses of $(0.11) per share from the same period last year.
Anebulo Pharmicals(纳斯达克股票代码:ANEB)公布季度每股亏损0.10美元,比分析师普遍估计的0.12美元(0.12美元)高出16.67%。这比去年同期每股亏损0.11美元(0.11美元)增加了9.09%。